Integra LifeSciences Holdings Corp Stock News

Integra's (IART) international sales in CSS grow led by the strong performance of CereLink in Europe and growth in Asia.

Integra's (IART) updated 2022 financial guidance calls for strong year-over-year organic growth.

IART vs. EW: Which Stock Is the Better Value Option?

Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants Jan De Witte – President & Chief Executive Officer Glenn Cole

Integra (IART) delivered earnings and revenue surprises of 8.82% and 3.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Investors are optimistic about Integra (IART), given the strength in its CSS arm and notable product launches.

Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial r

Integra (IART) reported earnings 30 days ago. What's next for the stock?

Integra's (IART) NeuraGen 3D will provide surgeons with access to the latest technology in peripheral nerve repair.

Let's see if Integra LifeSciences (IART) stock is a good choice for value-oriented investors right now from multiple angles.

Integra (IART) records strong recovery in order demand in Q4 on broad-based strength in Neurosurgery and sales from the company's new CereLink ICP monitoring.

Pune, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Global Medical Collagen Market report delivers a complete overview of key components like drivers, limitations, historic and current trends, technical development, and future growth. Research report contains company analysis, size, share, revenue and sales of the company, current advancements. Medical Collagen market analysis also focuses on the global key top industry players in the market, with details such as company profiles, capacity, production, price, cost, revenue. The global Medical Collagen market size is estimated to be worth USD 236.3 million in 2022 and is forecast to a readjusted size of USD 396.3 million by 2028 with a CAGR of 9.0% during the review period. Get a Sample Copy of the Report at - https://www.absolutereports.com/enquiry/request-sample/19862120 Medical collagen is a commonly used medical consumable in surgery, which can act as a filler, stop bleeding quickly, prevent adhesion, accelerate wound healing and reduce postoperative complications.